A new treatment for advanced pancreatic cancer has been approved by the Food and Drug Administration. This approval offers new life-extending care for patients with this aggressive form of cancer.

The FDA's decision was made on Wednesday, marking a significant development in the treatment of pancreatic cancer.

Further details about the treatment and its implications are available from the source, providing more information for those affected by this disease.